Pharma IT ApS: Financial statements 2025
CVR: 37320595
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma IT ApS (CVR 37320595) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 137,832,741 and a net result of DKK -1,068,285 compared with DKK 21,437,534 the year before. That is a decrease of 15.6% compared with the year before. Equity in the 2025 report amounted to DKK 47,568,805. The solvency ratio was 46%. The company had 110 employees in the financial year.
- Gross Profit
- DKK 137,832,741
- Profit/Loss
- DKK -1,068,285
- Equity
- DKK 47,568,805
- Total Assets
- DKK 103,410,450
- Employees
- 110
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 137.8 mio. | -1.1 mio. | 47.6 mio. | 110 |
| 2024 | - | 163.3 mio. | 21.4 mio. | 51.1 mio. | 112 |
| 2023 | - | 149.9 mio. | 13.3 mio. | 29.7 mio. | 124 |
| 2022 | - | 138.6 mio. | 14.1 mio. | 16.4 mio. | 117 |
| 2021 | - | 84 mio. | 5.2 mio. | 8.3 mio. | 75 |
How creditworthy is Pharma IT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 14, 2025, Massimo Cunico has joined the board of directors of Pharma IT ApS.
As of November 14, 2025, Xavier Duburq has left the board of directors of Pharma IT ApS.
Pharma IT ApS has published its annual report for 2024. Gross profit came to DKK 163,256,837, and the net result was DKK 21,437,534.
About Pharma IT ApS
Pharma IT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Søren Winkel, Jakob Juul Rasmussen and Peter-Emil Iversen. The board consists of Massimo Cunico (chair), Jakob Juul Rasmussen and Søren Winkel. The company is owned by ProductLife ApS. The company has 31 employees (2018). In 2025, the company reported a gross profit of DKK 137,832,741 and a net result of DKK -1,068,285 compared with DKK 21,437,534 the year before. Equity in the 2025 report amounted to DKK 47,568,805.